The prevalence of cleft palate in Finland is more than twice the European average. A research team identified genetic variants that explain this phenomenon, as well as a regional distribution where cleft cases increase from southwest to northeast.
FinnGen, a forerunner in the global landscape of genomics projects, is delighted to welcome Bayer as its newest pharmaceutical industry partner.